Pharmacokinetics of Inhaled Monodisperse Fluticasone Propionate

NCT00692978 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Healthy
Asthma

Interventions

DRUG: Fluticasone Propionate_1.5
DRUG: Fluticasone Propionate_3
DRUG: Fluticasone Propionate_6
DRUG: FP From Active 250 ug MDI Inhaler

Sponsor

Imperial College London